Robert C. Goeltz II
Chief Financial Officer at Arcus Biosciences · 6 reported transactions in 1 company · latest trade Dec 31, 2025
Their trades
Sold | Dec 31, 2025 | Dec 31, 2025 close $23.83 → Oct 30, 2026 close $18.02. S&P 500 +13.3% over the same days. | ||
Sold | Dec 17, 2025 | Dec 17, 2025 close $22.28 → Oct 30, 2026 close $18.02. S&P 500 +15.0% over the same days. | ||
Sold | Dec 16, 2025 | Dec 16, 2025 close $22.20 → Oct 30, 2026 close $18.02. S&P 500 +13.8% over the same days. | ||
Sold | Nov 26, 2025 | Nov 26, 2025 close $25.56 → Oct 30, 2026 close $18.02. S&P 500 +13.6% over the same days. | ||
Sold | Oct 28, 2025 | Oct 28, 2025 close $19.88 → Oct 30, 2026 close $18.02. S&P 500 +12.4% over the same days. |
$153.2K
Dec 31, 2025 close $23.83 → Oct 30, 2026 close $18.02. S&P 500 +13.3% over the same days.
$132.1K
Dec 17, 2025 close $22.28 → Oct 30, 2026 close $18.02. S&P 500 +15.0% over the same days.
$146.7K
Dec 16, 2025 close $22.20 → Oct 30, 2026 close $18.02. S&P 500 +13.8% over the same days.
$125K
Nov 26, 2025 close $25.56 → Oct 30, 2026 close $18.02. S&P 500 +13.6% over the same days.
$100K
Oct 28, 2025 close $19.88 → Oct 30, 2026 close $18.02. S&P 500 +12.4% over the same days.